Phathom Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PHAT and other ETFs, options, and stocks.About PHAT
Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.
CEOSteven L. Basta
CEOSteven L. Basta
Employees427
Employees427
HeadquartersFlorham Park, New Jersey
HeadquartersFlorham Park, New Jersey
Founded2018
Founded2018
Employees427
Employees427
PHAT Key Statistics
Market cap582.95M
Market cap582.95M
Price-Earnings ratio-1.59
Price-Earnings ratio-1.59
Dividend yield—
Dividend yield—
Average volume935.92K
Average volume935.92K
High today$8.50
High today$8.50
Low today$8.18
Low today$8.18
Open price$8.40
Open price$8.40
Volume501.93K
Volume501.93K
52 Week high$19.71
52 Week high$19.71
52 Week low$2.21
52 Week low$2.21
Analyst ratings
89%
of 9 ratingsBuy
88.9%
Hold
11.1%
Sell
0%
People also own
Based on the portfolios of people who own PHAT. This list is generated using Robinhood data, and it’s not a recommendation.